ASX - By Stock
|
NUZ |
Healey Platform the field so far.
|
|
kpax
|
3 |
1.7K |
38 |
27/08/24 |
27/08/24 |
ASX - By Stock
|
3
|
1.7K
|
38
|
|
ASX - By Stock
|
NUZ |
Re:
Ann: Positive Interim Study Results from OLE Study in ALS
|
|
kpax
|
68 |
20K |
34 |
26/08/24 |
26/08/24 |
ASX - By Stock
|
68
|
20K
|
34
|
|
ASX - By Stock
|
NUZ |
Re:
Ann: Positive Interim Study Results from OLE Study in ALS
|
|
kpax
|
68 |
20K |
53 |
26/08/24 |
26/08/24 |
ASX - By Stock
|
68
|
20K
|
53
|
|
ASX - By Stock
|
NUZ |
Re:
Pitney Pharmaust patents valuation - Kpax
|
|
kpax
|
29 |
9.3K |
65 |
23/08/24 |
23/08/24 |
ASX - By Stock
|
29
|
9.3K
|
65
|
|
ASX - By Stock
|
NUZ |
Pitney Pharmaust patents valuation - Kpax
|
|
kpax
|
29 |
9.3K |
48 |
23/08/24 |
23/08/24 |
ASX - By Stock
|
29
|
9.3K
|
48
|
|
ASX - By Stock
|
NUZ Biotech |
Re:
Phase II Begins, Cashed Up with Healey In the Sights of Big Pharma $$$
|
|
kpax
|
463 |
145K |
14 |
15/08/24 |
15/08/24 |
ASX - By Stock
|
463
|
145K
|
14
|
|
ASX - By Stock
|
NUZ |
Re:
Pharmaust - Media & News
|
|
kpax
|
260 |
90K |
27 |
14/08/24 |
14/08/24 |
ASX - By Stock
|
260
|
90K
|
27
|
|
ASX - By Stock
|
NUZ |
Re:
Latest MND Webinar information on Monepantel
|
|
kpax
|
33 |
9.1K |
36 |
08/08/24 |
08/08/24 |
ASX - By Stock
|
33
|
9.1K
|
36
|
|
ASX - By Stock
|
NUZ |
Re:
Latest MND Webinar information on Monepantel
|
|
kpax
|
33 |
9.1K |
12 |
07/08/24 |
07/08/24 |
ASX - By Stock
|
33
|
9.1K
|
12
|
|
ASX - By Stock
|
NUZ |
Latest MND Webinar information on Monepantel
|
|
kpax
|
33 |
9.1K |
49 |
07/08/24 |
07/08/24 |
ASX - By Stock
|
33
|
9.1K
|
49
|
|
ASX - By Stock
|
NUZ |
Re:
Company presenting at Techknow in Sydney (today)/ Melbourne (tomorrow)
|
|
kpax
|
68 |
15K |
34 |
01/08/24 |
01/08/24 |
ASX - By Stock
|
68
|
15K
|
34
|
|
ASX - By Stock
|
NUZ |
Re:
Pharmaust - Media & News
|
|
kpax
|
260 |
90K |
43 |
26/07/24 |
26/07/24 |
ASX - By Stock
|
260
|
90K
|
43
|
|
ASX - By Stock
|
ATH |
Re:
Ann: Positive Interim Data from ATH434-202 Phase 2 Clinical Trial
|
|
kpax
|
169 |
50K |
3 |
17/07/24 |
17/07/24 |
ASX - By Stock
|
169
|
50K
|
3
|
|
ASX - By Stock
|
ATH |
Re:
Ann: Positive Interim Data from ATH434-202 Phase 2 Clinical Trial
|
|
kpax
|
169 |
50K |
19 |
17/07/24 |
17/07/24 |
ASX - By Stock
|
169
|
50K
|
19
|
|
ASX - By Stock
|
SNT |
Re:
Syntara the science explained
|
|
kpax
|
96 |
37K |
21 |
15/07/24 |
15/07/24 |
ASX - By Stock
|
96
|
37K
|
21
|
|
ASX - By Stock
|
NUZ |
Re:
Ann: PharmAust Granted SME Status by European Medicines Agency
|
|
kpax
|
15 |
6.4K |
37 |
01/07/24 |
01/07/24 |
ASX - By Stock
|
15
|
6.4K
|
37
|
|
ASX - By Stock
|
SNT |
Re:
Syntara the science explained
|
|
kpax
|
96 |
37K |
13 |
19/06/24 |
19/06/24 |
ASX - By Stock
|
96
|
37K
|
13
|
|
ASX - By Stock
|
NUZ |
Re:
Pharmaust - Media & News
|
|
kpax
|
260 |
90K |
32 |
16/06/24 |
16/06/24 |
ASX - By Stock
|
260
|
90K
|
32
|
|
ASX - By Stock
|
SNT |
Re:
Syntara the science explained
|
|
kpax
|
96 |
37K |
15 |
07/06/24 |
07/06/24 |
ASX - By Stock
|
96
|
37K
|
15
|
|
ASX - By Stock
|
NUZ |
Re:
Ann: OLE Study update reveals impressive Survival Data
|
|
kpax
|
248 |
71K |
41 |
05/06/24 |
05/06/24 |
ASX - By Stock
|
248
|
71K
|
41
|
|
ASX - By Stock
|
NUZ Biotech |
Re:
PAA, A New Dawn , FDA ODD Approval and Entering Phase II MND Trial
|
|
kpax
|
978 |
280K |
14 |
03/06/24 |
03/06/24 |
ASX - By Stock
|
978
|
280K
|
14
|
|
ASX - By Stock
|
SNT |
Re:
Syntara the science explained
|
|
kpax
|
96 |
37K |
15 |
31/05/24 |
31/05/24 |
ASX - By Stock
|
96
|
37K
|
15
|
|
ASX - By Stock
|
SNT |
Re:
Syntara the science explained
|
|
kpax
|
96 |
37K |
15 |
29/05/24 |
29/05/24 |
ASX - By Stock
|
96
|
37K
|
15
|
|
ASX - By Stock
|
SNT |
Re:
Syntara the science explained
|
|
kpax
|
96 |
37K |
14 |
24/05/24 |
24/05/24 |
ASX - By Stock
|
96
|
37K
|
14
|
|
ASX - By Stock
|
SNT |
Re:
SNT JustStocks Video on YouTube
|
|
kpax
|
40 |
12K |
2 |
23/05/24 |
23/05/24 |
ASX - By Stock
|
40
|
12K
|
2
|
|
ASX - By Stock
|
SNT |
Re:
SNT JustStocks Video on YouTube
|
|
kpax
|
40 |
12K |
4 |
23/05/24 |
23/05/24 |
ASX - By Stock
|
40
|
12K
|
4
|
|
ASX - By Stock
|
NUZ Biotech |
Re:
PAA, A New Dawn , FDA ODD Approval and Entering Phase II MND Trial
|
|
kpax
|
978 |
280K |
54 |
23/05/24 |
23/05/24 |
ASX - By Stock
|
978
|
280K
|
54
|
|
ASX - By Stock
|
SNT |
Syntara the science explained
|
|
kpax
|
96 |
37K |
28 |
23/05/24 |
23/05/24 |
ASX - By Stock
|
96
|
37K
|
28
|
|
ASX - By Stock
|
SNT |
Re:
SNT JustStocks Video on YouTube
|
|
kpax
|
40 |
12K |
6 |
21/05/24 |
21/05/24 |
ASX - By Stock
|
40
|
12K
|
6
|
|
ASX - By Stock
|
SNT |
Re:
SNT JustStocks Video on YouTube
|
|
kpax
|
40 |
12K |
4 |
21/05/24 |
21/05/24 |
ASX - By Stock
|
40
|
12K
|
4
|
|
ASX - By Stock
|
NUZ Biotech |
Re:
PAA, A New Dawn , FDA ODD Approval and Entering Phase II MND Trial
|
|
kpax
|
978 |
280K |
11 |
20/05/24 |
20/05/24 |
ASX - By Stock
|
978
|
280K
|
11
|
|
ASX - By Stock
|
NUZ |
Re:
Ann: PharmAust receives Orphan Drug Designation for monepantel
|
|
kpax
|
43 |
13K |
36 |
18/05/24 |
18/05/24 |
ASX - By Stock
|
43
|
13K
|
36
|
|
ASX - By Stock
|
NUZ |
Re:
Ann: Board Changes
|
|
kpax
|
250 |
69K |
14 |
12/05/24 |
12/05/24 |
ASX - By Stock
|
250
|
69K
|
14
|
|
ASX - By Stock
|
NUZ |
Re:
Ann: Board Changes
|
|
kpax
|
250 |
69K |
15 |
12/05/24 |
12/05/24 |
ASX - By Stock
|
250
|
69K
|
15
|
|
ASX - By Stock
|
NUZ |
Re:
Ann: Board Changes
|
|
kpax
|
250 |
69K |
12 |
11/05/24 |
11/05/24 |
ASX - By Stock
|
250
|
69K
|
12
|
|
ASX - By Stock
|
NUZ |
Re:
Ann: Trading Halt
|
|
kpax
|
83 |
26K |
37 |
08/05/24 |
08/05/24 |
ASX - By Stock
|
83
|
26K
|
37
|
|
ASX - By Stock
|
NUZ |
Re:
Corporate action
|
|
kpax
|
239 |
70K |
17 |
07/05/24 |
07/05/24 |
ASX - By Stock
|
239
|
70K
|
17
|
|
ASX - By Stock
|
NUZ |
Re:
Corporate action
|
|
kpax
|
239 |
70K |
14 |
07/05/24 |
07/05/24 |
ASX - By Stock
|
239
|
70K
|
14
|
|
ASX - By Stock
|
NUZ |
Re:
Corporate action
|
|
kpax
|
239 |
70K |
37 |
07/05/24 |
07/05/24 |
ASX - By Stock
|
239
|
70K
|
37
|
|
ASX - By Stock
|
NUZ |
Re:
Corporate action
|
|
kpax
|
239 |
70K |
30 |
03/05/24 |
03/05/24 |
ASX - By Stock
|
239
|
70K
|
30
|
|
ASX - By Stock
|
NUZ |
Re:
Ann: Appendix 4C & Quarterly Update
|
|
kpax
|
104 |
23K |
16 |
03/05/24 |
03/05/24 |
ASX - By Stock
|
104
|
23K
|
16
|
|
ASX - By Stock
|
NUZ |
Re:
Ann: Appendix 4C & Quarterly Update
|
|
kpax
|
104 |
23K |
25 |
02/05/24 |
02/05/24 |
ASX - By Stock
|
104
|
23K
|
25
|
|
ASX - By Stock
|
NUZ Biotech |
Re:
The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst
|
|
kpax
|
1.4K |
393K |
24 |
01/05/24 |
01/05/24 |
ASX - By Stock
|
1.4K
|
393K
|
24
|
|
ASX - By Stock
|
NUZ |
Re:
Ann: Appendix 4C & Quarterly Update
|
|
kpax
|
104 |
23K |
47 |
30/04/24 |
30/04/24 |
ASX - By Stock
|
104
|
23K
|
47
|
|
ASX - By Stock
|
NUZ Biotech |
Re:
The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst
|
|
kpax
|
1.4K |
393K |
19 |
12/04/24 |
12/04/24 |
ASX - By Stock
|
1.4K
|
393K
|
19
|
|
ASX - By Stock
|
NUZ Biotech |
Re:
The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst
|
|
kpax
|
1.4K |
393K |
51 |
09/04/24 |
09/04/24 |
ASX - By Stock
|
1.4K
|
393K
|
51
|
|
ASX - By Stock
|
NUZ |
Re:
Ann: Application for quotation of securities - PAA
|
|
kpax
|
1 |
1.1K |
4 |
05/04/24 |
05/04/24 |
ASX - By Stock
|
1
|
1.1K
|
4
|
|
ASX - By Stock
|
NUZ |
NZT gone but hasn't forgotten
|
|
kpax
|
66 |
20K |
62 |
03/04/24 |
03/04/24 |
ASX - By Stock
|
66
|
20K
|
62
|
|
ASX - By Stock
|
NUZ |
Re:
Ann: PharmAust to present at NWR Virtual Healthcare Conference
|
|
kpax
|
126 |
35K |
20 |
23/03/24 |
23/03/24 |
ASX - By Stock
|
126
|
35K
|
20
|
|
ASX - By Stock
|
NUZ |
Re:
Ann: PharmAust to present at NWR Virtual Healthcare Conference
|
|
kpax
|
126 |
35K |
22 |
22/03/24 |
22/03/24 |
ASX - By Stock
|
126
|
35K
|
22
|
|